Table 5-1 Melanoma Staging |
| Stage | | TNM | | Criteria |
| 0 | | Tis N0M0 | | Melanoma in situ |
| IA | | T1a N0M0 | | ≤ 1.0 mm without ulceration and mitotic rate <1/mm2 |
| IB | | T1b N0M0 T2a N0M0 | | ≤ 1.0 mm with ulceration or mitotic rate >1/mm2 1.01–2.0 mm without ulceration |
| IIA | | T2b N0M0 T3a N0M0 | | 1.01–2.0 mm with ulceration 2.01–4.0 mm without ulceration |
| IIB | | T3b N0M0 T4a N0M0 | | 2.01–4.0 mm with ulceration >4 mm without ulceration |
| IIC | | T4b N0M0 | | >4 mm with ulceration |
| IIIA | | T1-4a N1a M0
T1-4a N2a M0 | | Nonulcerated tumor with single regional nodal micrometastasis Nonulcerated tumor with 2–3 nodal micrometastasis |
| IIIB | | T1-4b N1a M0 T1-4b N2a M0 T1-4a N1b M0 T1-4a N2b M0 T1-4a/b N2c M0 | | Ulcerated tumor with single regional nodal micrometastasis Ulcerated tumor with 2–3 nodal micrometastasis Nonulcerated tumor with single regional nodal macrometastasis Nonulcerated tumor with 2–3 nodal macrometastasis In-transit met(s) and/or satellite lesion(s) without metastatic LNs |
| IIIC | | T1-4b N2a M0 T1-4b N2b M0 T1-4a/b N3M0 | | Ulcerated tumor with macrometastasis of one lymph node Ulcerated tumor with macrometastasis in 2–3 lymph nodes Tumor with four or more metastatic nodes, matted nodes or in transit mets/satellite lesion(s) with metastatic nodes
|
| IV | | Any T, any N, M1a Any T, any N, M1b Any T, any N, M1c | | Distant skin, subcutaneous, or lymph node metastasis Lung metastasis Visceral or any distant metastasis + elevated LDH |
| | | | | |